considered squamous metaplasia as a characteristic change, specific to chemically-induced breast cancer, and pointed out that the different histological appearance of methylcholanthrene-induced and spontaneous breast tumours may be the expression of a different origin of these two types of breast cancer. They found, however, a higher incidence and an earlier appearance of methylcholanthrene-induced breast cancer in mice of a strain known to possess the mammary tumour agent (milk factor) than in mice of the same strain deprived of it. This observation suggested a relationship between spontaneous and induced manmmary tumours, namely, that the mammary tumour agent may take part in the origin of both types of tumours.
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Although their observations indicated a certain strain specificity to the development of methylcholanthrene-induced mammary tumours, the relationship between susceptibility to the development of spontaneous and methylcholanthrene-induced breast cancer remained uncertain. In another series of experiments, Kirschbaum, Williams and Bittner (1946) came to the conclusion that the histogenesis of breast tumours induced with methylcholanthrene is the same either in the presence or in the absence of the mammary tunaour agent and differs from that of spontaneous breast cancer in mice of the same strain. In spite of the previously observed difference between the incidence of methylcholanthrene-induced breast cancer in mice with the mammary tumour agent and in mice of the same strain deprived of the agent, Kirschbaum, Williams and Bittner (1946) were inclined to postulate a different aetiology for spontaneous and induced breast cancer because of the observed differences in the histogenesis of these two types of tumours. Strong (1945) considered that the action of methylcholanthrene may either involve a reversal of genetic resistance to the development of breast tumours or lead to the manifestation of a new type of susceptibility different from that involved in spontaneous breast tumours. Thus it was not clear whether the origin of breast tumours induced by methylcholanthrene was the same as or different from that of spontaneous mammary cancer, and the part played by the mammary tumour agent in the development of chemically-induced tumours required clarification. The possibility that the action of methylcholanthrene may result in the appearance of the mammary tumour agent in mnice of strains known to lack the agent also required investigation.
In connection with the work quoted and the results described in a previous paper (Dmochowski and Orr, 1949) experiments were carried out in order to find out if the milk factor plays a part in the development of mammary tumours induced with methylcholanthrene.
MATERIAL AND METHODS.
Breast tumours of C3H high-and C57 low-breast-cancer strain male mice induced by combined application of oestrone and methylcholanthrene, of C3H males following treatment with oestrone, and of C57 females after treatment with methylcholanthrene were investigated for the presence of the mammary tumour agent. In addition, breast tumours induced in IF low-breast-cancer strain mice with methylcholanthrene (Orr, 1946) were also examined.
Breast tumour tissue desiccated and stored for periods of time varying from 1 week to 7 months was used. The tumour tissue, immediately before use, was resuspended in distilled water in a proportion of 1:10 and injected subcutaneously every other day into 4-6 weeks old susceptible C57 x RIII hybrid female mice. All females were forcibly bred by removing the first three litters and then allowed to breed in a normal way.
EXPERIMENTAL PROCEDURE AND RESULTS. Experiment 1.
Four breast tumours induced in IF low-breast-cancer strain females with methylcholanthrene and one breast tumour induced in a C3H male with oestrone and methylcholanthrene were tested for the presence of the mammary tumour agent.
Thirty-six C57 x RIII hybrid females which were litter mates were divided into 5 groups.
The first group of C57 x RIII hybrid females received 5 injections, each of 0. (Dmochowski and Orr, 1949 ) comprising a total of 0-4 g. of fresh tumour tissue.
As can be seen from Table I , no breast tumours developed in any of the C57 x RIII susceptible hybrid mice given repeated injections of distilled water suspensions of dried breast tumours induced in IF low-breast-cancer strain mice with methylcholanthrene. During this time 4 out of 6 C57 x RIII hybrids, given breast tumour tissue induced in a C3H high-breast-cancer strain male mouse with oestrone and methylcholanthrene, developed breast tumours. All tumours were examined microscopically and were found to be adenocarcinomata. It can be concluded that the mammary tumour agent is present in tumours induced in C3H strain males by combined application of oestrone and methylcholanthrene. Tumours induced in IF low-breast-cancer strain female mice do not seem to harbour the agent. Experiment 2.
Six mammary tumours, 2 induced in C33H strain males by painting with oestrone, 2 which developed in C3H strain males after treatment with oestrone --;: ;: e" qD and methylcholanthrene, one induced in a 057 strain breeding female with methylcholanthrene and one in a C57 strain male with oestrone and methylcholanthrene (Dmochowski and Orr, 1949) were tested for the presence of the mammary tumour agent.
Altogether 36 C57 x RIII hybrid females were employed in the experiment, and 6 mice were used for each of the tested tumours.
Mice of the first group were given C3H male No. 25 (Kirschbaum, Williams and Bittner, 1946) and also strain NHO (Strong, 1945) are susceptible, C57 black strain used by Kirschbaum, Williams and Bittner (1946) is not susceptible under the conditions of administration of methylcholanthrene employed by these workers. The sub-line of C57 black low-breast-cancer strain maintained in this department is susceptible, but to a less degree than IF low-breast-cancer strain mice, to the induction of breast cancer following the application of methylcholanthrene by the present method. Our C57 black strain mice do not develop breast cancer when given material containing the mammary tumour agent at the age of 4-6 weeks, even after large quantities of the material and in spite of increased hormonal stimulation (repeated pregnancies). This indicates that mature mice of this strain, though resistant to the mammary tumour agent, are susceptible to a different agent, namely, methylcholanthrene.
The development of breast tumours in both high-and low-breast-cancer strain mice after treatment with methylcholanthrene, the differences in the susceptibility to the development of these tumours between various strains which possess the agent as well as between strains which lack the agent, the absence of the agent in induced breast tumours of low-breast-cancer strain mice, although such tumours are similar in microscopical appearance to induced breast tumours of high-breast-cancer strain mice, support the conclusion that the action of methylcholanthrene in the induction of breast cancer is independent of the milk factor.
The results of the tests for the presence of the mammary tumour agent in breast tumours induced in low-cancer strain mice seem to support the conclusion that the type of susceptibility operative in the development of methylcholan-threne-induced breast tumours differs from that involved in the origin of spontaneous breast cancer. The susceptibility to spontaneous breast cancer may be different from the susceptibility to chemically-induced breast cancer because mice which show low susceptibility to the mammary tumour agent may show a high susceptibility to methylcholanthrene, and vice versa. The results of our tests for the presence of the milk factor in methylcholanthrene-induced breast tumours in low-breast-cancer strain miice show that methylcholanthrene does not induce the appearance of the factor in mice of strains which are known to lack it.
SUMMARY.
The present experiments have shown the mammary tumour agent to be present in breast tumours induced in C3H high-breast-cancer strain males, following application of methylcholanthrene and oestrogen, or oestrogen alone.
Biological tests have not revealed the agent in breast cancer induced in C57 black low-breast-cancer strain males, after the application of oestrogen and methylcholanthrene. Breast tumours induced in C57 black and IF low-breastcancer strain females by methylcholanthrene do not contain the mammary tumour agent.
The part played by the carcinogenic hydrocarbons in the induction of breast cancer in mice is discussed.
